X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

MCRB

Closed

Seres Therapeutics Inc

10.705
-0.405 (-3.65%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 11.11
Day's Range: 9.8006 - 11.11
Send
When Written:
 
5.67
Seres Therapeutics Inc is a biotechnology company that develops microbiome therapeutics. The company's lead product candidate, SER-109, is being developed for the treatment of recurrent Clostridioides difficile infection (CDI). The company's microbiome therapeutics platform is based on the understanding that the human microbiome plays a critical role in human health and disease. Seres Therapeutics Inc was founded in 2010 and is headquartered in Cambridge, Massachusetts. The company is publicly traded on the NASDAQ under the ticker symbol MCRB.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X